Tatjana
Tatjana Avkina, Apex, NC US
Patent application number | Description | Published |
---|---|---|
20110151570 | METHOD FOR ON-SITE DRUG DETECTION IN ILLICIT DRUG SAMPLES - The invention is provided for detection of Heroin and Morphine in illicit drug samples, also for their differentiation. A liquid sample from a street sample is prepared and divided into two equal aliquots, one of them being reference sample, another being main sample. Both samples are treated with Hydrochloric acid and Sodium hydroxide, but those substances are added to the samples in the different sequence. After that the measurement of SFS of the reference sample is performed. Further the presence of specific spectral pattern of Morphine in the measured SFS of the reference, sample is detected and the value of SFS intensity at the specific spectral point is fixed (a reference value). After 15 minutes for acidification of the main sample, the analogous measurement and detection of the Morphine in the main sample are performed. | 06-23-2011 |
Tatjana Banovic, Queensland AU
Patent application number | Description | Published |
---|---|---|
20100099605 | CHAPERONIN 10 IMMUNOSUPPRESSION - The invention is directed to the use of cpn10 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease. | 04-22-2010 |
20120082690 | CHAPERONIN 10 IMMUNOSUPPRESSION - The invention is directed to the use of cpn10 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease. | 04-05-2012 |
Tatjana Crnogorac-Jurcevic, Chislehurst GB
Patent application number | Description | Published |
---|---|---|
20130045884 | MEANS AND METHODS FOR DIAGNOSING PANCREATIC CANCER - The present invention pertains to the field of cancer diagnosis. Specifically, it relates to a method for diagnosing pancreas cancer in a subject comprising the steps of determining in a sample of a subject suspected to suffer from pancreas cancer the amount of at least one biomarker selected from the biomarkers shown in Table 1 and comparing the said amount of the at least one biomarker with a reference, whereby pancreas cancer is to be diagnosed. The present invention also contemplates a method for identifying whether a subject is in need of a pancreas cancer therapy comprising the steps of the aforementioned methods and the further step of identifying a subject in need of a pancreas cancer therapy if said subject is to be diagnosed to suffer from pancreas cancer. Contemplated are, furthermore, diagnostic devices and kits for carrying out said methods. | 02-21-2013 |
Tatjana Dedova, Tallinn EE
Patent application number | Description | Published |
---|---|---|
20080280058 | Method of Preparing Zinc Oxide Nanorods on a Substrate By Chemical Spray Pyrolysis - A method of preparing nanostructured zinc oxide layers on a substrate by chemical spray pyrolysis at moderate deposition temperatures from 350° C. to 600° C. is disclosed. An aqueous or aqueous alcoholic solution comprising zinc chloride or zinc acetate as precursors is prepared and sprayed onto the preheated substrate so that the precursor reacts to form zinc oxide layer on the substrate. Thiourea or urea may be also added to the solution. Glass, silicon, or metal oxide covered glass can be used as the substrate. | 11-13-2008 |
20100186805 | PHOTOVOLTAIC CELL BASED ON ZINC OXIDE NANORODS AND METHOD FOR MAKING THE SAME - A new photovoltaic (PV) cell structure, prepared on transparent substrate with transparent conductive oxide (TCO) layer and having nanorod zinc oxide layer. The cell has a thin conductive layer of doped zinc oxide deposited on the nanorod zinc oxide layer, an extremely thin blocking layer of titanium oxide or indium sulfide on the thin conductive layer, a buffer layer of indium sulfide on the extremely thin blocking layer, an absorber layer, comprising copper indium disulfide on said buffer layer and one electrode attached to the transparent conductive oxide layer and a second electrode attached to the absorber layer. Also, a method of preparing a zinc oxide nanorod PV cell entirely by chemical spray pyrolysis is disclosed. Efficiency up to 3.9% is achieved by simple continuous non-vacuum process. | 07-29-2010 |
20130236646 | METHOD OF PREPARING ZINC OXIDE NANORODS ON A SUBSTRATE BY CHEMICAL SPRAY PYROLYSIS - A method of preparing nanostructured zinc oxide layers on a substrate by chemical spray pyrolysis at moderate deposition temperatures from 350.degree. C. to 600.degree. C. is disclosed. An aqueous or aqueous alcoholic solution comprising zinc chloride or zinc acetate as precursors is prepared and sprayed onto the preheated substrate so that the precursor reacts to form zinc oxide layer on the substrate. Thiourea or urea may be also added to the solution. Glass, silicon, or metal oxide covered glass can be used as the substrate. | 09-12-2013 |
Tatjana Dutova, Limerick City IE
Patent application number | Description | Published |
---|---|---|
20120022398 | BIOPSY DEVICE - A mechanism for sequentially loading and unloading a biopsy instrument includes a first wheel operatively connected with a cannula, the first wheel being rotatably mounted upon an axle such that the axle urges rotation of the first wheel in a first direction to transfer the cannula and the first wheel to a loaded position, the first wheel being configured for selective rotation with respect to the axle in a second direction to transfer the cannula and the first wheel to an unloaded position. A second wheel is operatively connected with a stylet, the second wheel being configured to be rotated by the axle in the first direction when the first wheel is in the loaded position, the second wheel configured for rotation relative to the axle to transfer the stylet and second wheel from the loaded to unloaded position. The second wheel is operatively engaged with the first wheel to allow partial rotation of the second wheel in the second direction with respect to the first wheel and urging similar rotation of the first wheel in the second direction after at least some duration of relative rotation of the second wheel with respect to the second wheel. | 01-26-2012 |
Tatjana Ivkina, Manotick CA
Patent application number | Description | Published |
---|---|---|
20090321659 | METHOD FOR ON-SITE DRUG DETECTION IN ILLICIT DRUG SAMPLES - The invention is intended for illicit drug detection, preferably to Cocaine detection in street samples containing in addition to Cocaine also adulterants and/or diluents (also denominated as cutting agents) used for increasing the quantity of the product and/or for disguising the existence of Cocaine. The invention provides preparing of the liquid street sample, taking an aliquot of said sample, its analysis with help of SFS (Spectral Fluorescence Signatures) technology, fixing the result of analysis as a reference value, the subsequent acidification of the liquid sample, taking an aliquot of the acidified liquid sample and its analysis with help of SFS technology, fixing the result of analysis and comparing said result with the reference value. The result of comparison enables to differentiate between Cocaine Base and Cocaine hydrochloride in the street sample. | 12-31-2009 |
Tatjana Kasdorf, Andernach DE
Patent application number | Description | Published |
---|---|---|
20150024222 | METHOD FOR PASSIVATION OF STRIP BLACK PLATE - A process for passivation of strip steel plate, having the following steps: electrochemical treatment of the black plate by passing the black plate through an electrolyte to form an inert steel surface; rinsing the black plate; and application of an aqueous chromium-free treatment solution to at least one surface of the black plate to form a conversion layer that protects against corrosion and an adhesion layer for paints and organic coating materials. The black plate treated in accordance with this process is characterized by high corrosion resistance and has good bonding capacity for paints and organic coatings and therefore is very suitable as a substitute for tin-free steel (TFS or ECCS) and tinplate for the production of packagings, in particular cans. In contrast to the traditional manufacturing and passivation processes for tin-free steel and tinplate, no chromium VI, which is environmentally hazardous and hazardous to health, is used in this process. | 01-22-2015 |
Tatjana Knyazeva, Gauting DE
Patent application number | Description | Published |
---|---|---|
20130084300 | DIAGNOSIS AND PREVENTION OF CANCER CELL INVASION - The present invention relates to diagnostic and therapeutic methods in the field of malignant disorders. More particularly, the invention provides methods of determining the invasivity of malignant disorders and methods for reducing the invasivity of malignant disorders including the prevention or treatment of cancer cell invasion. | 04-04-2013 |
Tatjana Kruscha, Braunschweig DE
Patent application number | Description | Published |
---|---|---|
20100121501 | OPERATING DEVICE FOR A MOTOR VEHICLE - In a method for the operator control of a motor vehicle having a display for displaying variable information, a symbol assigned to a function pertaining to the motor vehicle is shown with the aid of the display, the viewing direction of an operator of the motor vehicle is ascertained, and the function pertaining to the motor vehicle is subsequently executed in response to recognition of an acoustic command assigned to the function pertaining to the motor vehicle, while the viewing direction is aimed toward the display. | 05-13-2010 |
Tatjana Mateovic, Ljubljana SL
Patent application number | Description | Published |
---|---|---|
20100183714 | GASTRORESISTANT PHARMACEUTICAL DOSAGE FORM COMPRISING N-(2-(2- PHTHALIMIDOETHOXY)-ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK-423) - The present invention relates to the pharmaceutical dosage forms which enable a controlled and/or a targeted delivery of an active substance to the selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (designated as LK 423). Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed. | 07-22-2010 |
Tatjana Meier, Hannover DE
Patent application number | Description | Published |
---|---|---|
20110064739 | MEDICAMENT, COMPOSITIONS, AND SUBSTANCES FOR TREATING AND IDENTIFYING ADENOCARCINOMA OF THE LUNG - The invention is based on the finding that in mammalian lungs c-myc acts as a molecular switch, specifically inducing an expression pattern in vivo, which results in prototypical mammalian adenocarcinoma of the lung and liver metastasis. A set of factors essential for the processes of tumorigenesis and tumor progression, i.e. cell cycle and apoptosis, cell growth, extracellular signaling, angiogenesis and invasion, is identified, whose expression is significantly changed. In particular, the expression pattern found uncovers the network of molecules leading to mammalian papillary adenocarcinomas of the lung. | 03-17-2011 |
Tatjana Mezini, Medford, MA US
Patent application number | Description | Published |
---|---|---|
20080206632 | BATTERY SEPARATOR - An alkaline battery includes a housing, a cathode disposed within the housing, an anode disposed within the housing, a separator disposed between the anode and the cathode, and an alkaline electrolyte contacting the anode and the cathode. The separator can include a tube having at an inner tube layer and an outer tube layer. The inner tube layer is disposed radially inward from the outer tube layer and no portion of the inner tube layer is disposed radially outward from any portion of the outer tube layer. The separator can also include a disc positioned at one end of the tube to create a closed end of the separator. | 08-28-2008 |
20110039148 | ALKALINE PRIMARY CELLS - A battery is described. The battery includes an anode, a cathode, a separator disposed between the cathode and the anode, and an electrolyte. The anode further includes manganese. | 02-17-2011 |
20110039149 | ALKALINE PRIMARY CELLS - A battery is described. The battery includes an anode, a cathode, a separator disposed between the cathode and the anode, and an electrolyte. The cathode further includes manganese. | 02-17-2011 |
20110039150 | ALKALINE PRIMARY CELLS - A battery is described. The battery includes an anode, a cathode, a separator disposed between the cathode and the anode, and an electrolyte. The electrolyte further includes manganese. The manganese is selected from the group consisting of: cesium permanganate (CsMnO | 02-17-2011 |
20110117413 | Alkaline Battery Separators with Ion-Trapping Molecules - Battery separators are disclosed which include an ion selective polymeric film, composite film, or multi-layer containing an immobilized chelating agent. | 05-19-2011 |
Tatjana Mezini, Bethel, CT US
Patent application number | Description | Published |
---|---|---|
20130130093 | ALKALINE BATTERY SEPARATORS WITH ION-TRAPPING MOLECULES - Battery separators are disclosed which include an ion selective polymeric film, composite film, or multi-layer containing an immobilized chelating agent. | 05-23-2013 |
Tatjana Mijatovic, Rhode St Genese BE
Patent application number | Description | Published |
---|---|---|
20100068198 | TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES - Targeting of select subunits of the Na | 03-18-2010 |
Tatjana Mosthof, Munich DE
Patent application number | Description | Published |
---|---|---|
20160125281 | Production Method for Portable Data Carriers - A method for producing a portable data carrier by means of a continuous production method, in particular a roll-to-roll method, includes the step of processing at least one foil in the form of roll goods. The unrolled foil is coated with an adhesive at least partially on at least one side. Subsequently, the foil is scored along at least one fold edge on at least one side of the foil. The foil is then folded along the scored fold edge in exact register and bonded. For this purpose the foil is folded in the direction of the side that is coated with adhesive, wherein the side coated with adhesive is arranged on the opposite side of the foil which has at least one scored fold edge, along which the folding is effected. Finally, data carriers are punched out in exact register from the at least one folded and bonded foil. | 05-05-2016 |
Tatjana Mueller, Hergerhausen DE
Patent application number | Description | Published |
---|---|---|
20130261175 | 2-PYRONES - The present invention relates to the use of compounds of the formula (I) for the care, preservation or improvement of the general condition or appearance of the skin or hair, and to preparations comprising compounds of the formula (I). | 10-03-2013 |
Tatjana Mueller, Hergershausen DE
Patent application number | Description | Published |
---|---|---|
20140335029 | USE OF CYCLOHEXANOL DERIVATIVES AS ANTIMICROBIAL ACTIVE COMPOUNDS - The present invention relates to the use of at least one cyclohexanol derivative of the formula (I) and/or (II) as antimicrobial active compound or as anti-acne, antidandruff, antiperspirant or deodorant active compound, to preparations comprising these compounds, and to specific cyclohexanol derivatives and to a process for the preparation thereof. | 11-13-2014 |
Tatjana Pekovic, Saint-Lambert CA
Patent application number | Description | Published |
---|---|---|
20140260306 | ENGINE STARTING SYSTEM USING STORED ENERGY - There is described a method for and system for starting at least one engine from a twin engine installation. The starting system comprises a first engine arrangement comprising a first electric machine having a single rotor dual stator configuration, a first dual channel power control unit coupled to the first electric machine, and a first dual channel full authority digital engine control (FADEC) coupled to the first dual channel power control unit; a second engine arrangement comprising a second electric machine having a single rotor dual stator configuration, a second dual channel power control unit coupled to the second electric machine, and a second dual channel full authority digital engine control (FADEC) coupled to the second dual channel power control unit; an energy storage unit coupled to the first engine arrangement and the second engine arrangement and having at least a first super-capacitor and a second super-capacitor; and a DC to DC converter configured to receive a first voltage level from a power source, increase the first voltage level to a second voltage level, and charge the first super-capacitor and the second super-capacitor to the second voltage level. | 09-18-2014 |
Tatjana Piljac, Zagreb HR
Patent application number | Description | Published |
---|---|---|
20090220603 | USE OF RHAMNOLIPIDS IN WOUND HEALING, TREATING BURN SHOCK, ATHEROSCLEROSIS, ORGAN TRANSPLANTS, DEPRESSION, SCHIZOPHRENIA AND COSMETICS - Various methods are provided, including wound healing with reduced fibrosis, treatment of burn shock, treatment and prevention of atherosclerosis, prevention and treatment of organ transplant rejection, treatment of depression and schizophrenia and treatment of the signs of aging, such as wrinkles, each of which uses administration of a composition containing one or more rhamnolipids as an active ingredient. | 09-03-2009 |
Tatjana Rat, Westerkappeln DE
Patent application number | Description | Published |
---|---|---|
20090160341 | DISCHARGE LAMP COMPRISING UV-PHOSPHOR - The invention is concerned with a discharge lamp provided with a gas discharge vessel comprising a gas filling with a discharge-maintaining composition, at least part of a wall of the discharge vessel being provided with a luminescent material comprising as a first UV-phosphor a lanthanide-activated lanthanum magnesium aluminate of formula Lai_xMgAlπOic>:Lnx, wherein the lanthanide Ln is selected from the group of Ce(III), Pr(III), Nd(III) and Gd(III), and 0.00106-25-2009 | |
Tatjana Samojlova, Leichlingen DE
Patent application number | Description | Published |
---|---|---|
20150291068 | DEVICE FOR ADJUSTING A MOTOR VEHICLE INTERIOR COMPONENT - The present invention relates to an adjusting device, in particular for a motor vehicle interior component, which is used, for example, for adjusting a vehicle seat and/or one of the components thereof. | 10-15-2015 |
Tatjana Sauka-Spengler, Glendale, CA US
Patent application number | Description | Published |
---|---|---|
20100311048 | Neural Crest Enhancers and Methods for Use - DNA enhancer sequences are provided for use in constructs to identify early stage embryonic cells. The enhancer sequences can be used in parallel with short-hairpin RNA in a vector construct for endogenously regulated gene knockdowns. The disclosed enhancer sequences can be used to isolate a selected population of early stage embryonic cells. | 12-09-2010 |
Tatjana Sauka-Spengler, Oxford GB
Patent application number | Description | Published |
---|---|---|
20130273596 | NEURAL CREST ENHANCERS AND METHODS FOR USE - DNA enhancer sequences are provided for use in constructs to identify early stage embryonic cells. The enhancer sequences can be used in parallel with short-hairpin RNA in a vector construct for endogenously regulated gene knockdowns. The disclosed enhancer sequences can be used to isolate a selected population of early stage embryonic cells. | 10-17-2013 |
Tatjana Serdar, Antibes FR
Patent application number | Description | Published |
---|---|---|
20090113366 | METHOD AND MECHANISM FOR PERFORMING TIMING AWARE VIA INSERTION - A method and system to insert redundant vias while preserving timing is disclosed. The system and method preserve the timing during redundant via insertion, which utilizes incremental timing and extraction updates. A budgeting based approach and a path based approach to the method are disclosed. The budgeting approach is faster, while the path based method has a better insight of the worst slack/slew for the entire design. | 04-30-2009 |
Tatjana Sikuljak, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20130125267 | Pesticidal Mixtures - The present invention, comprising: [(3S,4R,4aR,6S,6aS,12R,12a5,12b5)-3-(cyclopropanecarbonyloxy)-6,12-dihy-droxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-11H,12H-benzo[f]pyrano[4,3-b]chromen-4-yl]methyl cydopropanecarboxylate (compound II) and a pesticidal compound II; in synergistic effective amounts. | 05-16-2013 |
20130287844 | Agrochemical Formulation Comprising Encapsulated Pesticide - The present invention relates to microcapsules comprising a polyurea shell and a core, which contains a pesticide, a water-immiscible solvent A and at least 5 wt % of an aprotic, polar solvent B, which has a solubility in water from 0.5 to 20 g/l at 20° C., based on the total weight of the solvents in the core. It further relates to microcapsules comprising a shell and a core, which contains a pesticide and 2-heptanone; to a method for preparing said mircocapsules; to an aqueous composition comprising said microcapsules; and to a method for controlling phytopathogenic fungi and/or undesired plant growth and/or undesired attack by insects or mites and/or for regulating the growth of plants, with said mircocapsules. | 10-31-2013 |
20130295152 | Agrochemical Formulation Comprising Encapsulated Pesticide - The present invention relates to a aqueous composition containing a suspended pesticide A, and microcapsules comprising a shell and a core, wherein the core contains a pesticide B and an aprotic, polar solvent B, and the shell contains poly(meth)acrylate, which comprises C | 11-07-2013 |
20140364317 | SOLID AGROFORMULATIONS PREPARED FROM A MELT OF PESTICIDE AND POLYALKOXYLATE, OPTIONALLY CONTAINING LIQUID ADJUVANT COMPLEXED WITH POLYCARBOXYLATE - The present invention relates to a method for a preparation of a solid composition comprising the steps of a) dissolving a premix in a premix-solvent, or melting a premix, wherein the premix contains a pesticide and a nonionic, amphiphilic polyalkoxylate, b) solidifying the premix by removing the premix-solvent, or by cooling, and c) contacting the premix with at least one auxiliary. The invention further relates to a solid composition obtainable by said method; to a method for the preparation of an aqueous tank mix, in which a pesticide is present as suspended particles having a particle size below 1.0 μm, comprising the step of mixing water and a solid composition obtainable by the said method; and to a method for controlling phytopathogenic fungi and/or undesired plant growth and/or undesired attack by insects or mites and/or for regulating the growth of plants, where a solid composition obtainable by said method is allowed to act on the particular pests, their habitat or the plants to be protected from the particular pest, the soil and/or on undesired plants and/or the useful plants and/or their habitat. | 12-11-2014 |
20150056257 | EMULSIFIABLE GRANULE OBTAINABLE BY MIXING AN PESTICIDAL EMULSION WITH SOLID DISPERSANT AND EXTRUDING THE RESULTING PASTE - The present invention relates to a method for preparing an emulsifiable granule comprising the steps of a) emulsifying water with a solution of a pesticide in a water-insoluble solvent, b) contacting the emulsion resulting from step a) and a solid dispersant containing a water-soluble polycarboxylate and a water-soluble anionic surfactant, and c) extruding the paste resulting from step b). The invention further relates to emulsifiable granules containing a water-insoluble solvent, a pesticide, which is dissolved in the water-insoluble solvent, a water-soluble polycarboxylate, and a water-soluble anionic surfactant. | 02-26-2015 |
Tatjana Van Den Tempel, Klampenborg DK
Patent application number | Description | Published |
---|---|---|
20140141121 | MANUFACTURE OF CHEESE - The present invention relates to the manufacture of cheese, especially cottage cheese, by fermenting milk with lactic acid bacteria. | 05-22-2014 |
Tatjana Zikov, Cleveland Heights, OH US
Patent application number | Description | Published |
---|---|---|
20090018429 | Method and system for acquiring biosignals in the presence of HF interference - The present invention, herein is a method and apparatus that significantly limits the effect of high frequency (“HF”) interferences on acquired electro-physiological signals, such as the EEG and EMG. Preferably, this method comprises of two separate electronic circuitries and steps or electronics for processing the signals. One circuit is used to block the transmission of HF interferences to the instrumentation amplifiers. It is comprised of a front-end active filter, a low frequency electromagnetic interference (“EMI”) shield, and an isolation barrier interface which isolates the patient from earth ground. The second circuit is used to measure the difference in potential between the two isolated sides of the isolation barrier. This so-called “cross-barrier” voltage is directly representative of the interference level that the instrumentation amplifier is subjected to. This circuit is used to confirm that the acquired signals are not corrupted by the interference. | 01-15-2009 |
20110130675 | MULTI-CHANNEL BRAIN OR CORTICAL ACTIVITY MONITORING AND METHOD - The present invention relates to a quantitative electroencephalogram (QEEG) monitor and system capable of monitoring and displaying simultaneously neuropathological characteristic and activity of both sides of a subject's brain. The methods include various indices and examination of differences in these indices by which neurophysiological conditions or problems can be identified and treated. These methods, and the systems and devices using these methods preferably can be used for identifying these neurophysiological conditions or brain dysfunction with monitors and methods for seizure detection, for sedation monitoring, for anesthesia monitoring, and the like. These bilateral brain monitoring methods and systems, and the devices using these methods can be used by individuals or clinicians with little or no training in signal analysis or processing. These bilateral monitoring methods can also be used in a range of applications. | 06-02-2011 |
20110295096 | Method and system for electrode impedance measurement - The present invention relates to measuring electrical impedance, and particularly to measuring impedance of electrodes used to acquire physiological signals. The measurement of electrode impedance is typically performed to ensure proper electrode-to-skin contact, and thus verify the quality of the acquired signals. Electrode-to-skin contact impedance has also clinical utility for monitoring, diagnosis, prognosis or treatment, as it can be used to measure skin conductivity, which is function of physiological processes. The present invention relates in particular to a substantially continuous method for performing such measurement. The measurement is performed in such a way that it does not affect the bioband, the range (or ranges) of frequencies that contains components used for diagnostic, prognostic, triage, and/or treatment purposes. The present invention therefore performs this impedance measurement without affecting the physiological signal while allowing for uninterrupted monitoring of said signal. | 12-01-2011 |
20110295099 | Electrode kit for easy and fast deployment in electroencephalogram acquisition and monitoring applications - Electrodes for use in electroencephalographic recording, including consciousness and seizure monitoring applications, have novel features that speed, facilitate or enforce proper placement of the electrodes, including aligning tabs and arrowed aligning juts, color coding, and an insulating bridge between reference and ground electrodes which ensures a safe application distance between the conductive regions of the two electrodes in the event of cardiac defibrillation. A method of using a set of four such electrodes is also disclosed. | 12-01-2011 |
20110295142 | Detector for identifying physiological artifacts from physiological signals and method - The present invention relates to a physiological monitor and system, particularly to an electroencephalogram (EEG) monitor and system, and a method of detecting the presence and absence of artifacts and possibly removing artifacts from an EEG, other physiological signal or sensor signal without corrupting or compromising the signal. The accurate, real-time detection of the presence or absence of artifacts and removal of artifacts in EEG or other signals allows for increased reliability in the efficacy of those signals. The strategy of rejecting artifact-corrupted EEG can result in unacceptable data loss, and asking subjects to minimize movements in order to minimize artifacts is not always feasible. The present invention allows for increased accuracy in detection and removal of artifacts from physiological signals, substantially in real time, and without loss or corruption of signal or data in order to increase the accuracy of such signals for diagnosis and treatment purposes. | 12-01-2011 |
20140323900 | Multi-channel brain or cortical activity monitoring and method - The present invention relates to a quantitative electroencephalogram (QEEG) monitor and system capable of monitoring and displaying simultaneously neuropathological characteristic and activity of both sides of a subject's brain. The methods include various indices and examination of differences in these indices by which neurophysiological conditions or problems can be identified and treated. These methods, and the systems and devices using these methods preferably can be used for identifying these neurophysiological conditions or brain dysfunction with monitors and methods for seizure detection, for sedation monitoring, for anesthesia monitoring, and the like. These bilateral brain monitoring methods and systems, and the devices using these methods can be used by individuals or clinicians with little or no training in signal analysis or processing. These bilateral monitoring methods can also be used in a range of applications. | 10-30-2014 |
20150018657 | Physiological electrode assembly for fast application - The present invention relates to a physiological recording electrode, and, more particularly, to an EEG (electroencephalography) recording electrode that can be used without the need for numerous steps in preparing the subject's skin and the electrode itself. The invention further relates to a surface feature or penetrator with a size and shape which that will not bend or break, which limits the depth of application, and/or anchors the electrode or other device during normal application; and a packaging system comprising a well and electrolytic fluid for maintaining a coating of said electrolytic fluid on the surface feature or penetrator. | 01-15-2015 |
Tatjana Zikov, Shaker Heights, OH US
Patent application number | Description | Published |
---|---|---|
20080294063 | Method and apparatus for the estimation of anesthetic depth using wavelet analysis of the electroencephalogram - A method and apparatus to monitor the neurologic state of a patient undergoing general anesthesia is provided. Previous automated systems to monitor the neurologic state of a patient undergoing general anesthesia involve a significant time delay between the patients true hypnotic state and the computed indices. The present invention reduces this time delay by using a different analysis technique applied to spontaneous EEG. A wavelet decomposition and statistical analysis of the observed EEG is conducted and compared to reference data to provide a numerical indicator. In addition, this indicator is more consistent with the patient's loss of consciousness indicated by the loss of count event than previous systems. | 11-27-2008 |